Nath Bio-Genes (India) Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018

Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018

1. The financial results were reviewed by the Audit Committee in meeting held on February 01, 2019 and were thereafter approved by the Board of Directors at its meeting held on February 02, 2019.

2. The company has adopted Indian Accounting Standards (Ind ASs) w.e.f. 01 April 2017 with a transition data of 01 April 2016. Accordingly the corresponding Quarterly and year-to-date results of the previous year have been restated, where applicable.

3. The company is dealing in one major product segment, i.e. Research, Production, Processing & Marketing of Seeds

4. The figures have been regrouped / rearranged where ever necessary.

Satish Kagliwal
Managing Director